Australia Biotechnology & Medical Research

Anteotech Ltd (ADO)

Track

Track

Anteotech Ltd has recorded no insider trading activity within the last three months. The most recent transactions occurred on November 14, 2023, involving various planned purchases and acquisitions by company personnel. Historical data indicates a mix of buying and selling patterns among key stakeholders over previous years.
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Katherine Woodthorpe Director
Transaction date
Purchase
Price
334.08
Quantity 46,002
Value A$4,751,350
Glenda McLoughlin Director
Transaction date
Planned purchase
Price
206.11
Quantity 42,984
Value A$1,266,903
Geoff Cumming Director
Transaction date
Planned purchase
Price
290.46
Quantity 89,374
Value A$1,740,138
Ewen Crouch Director
Transaction date
Planned purchase
Price
0.03
Quantity 44
Value A$1
David John Radford Director
Transaction date
Planned purchase
Price
0.03
Quantity 44
Value A$1
David John Radford Director
Transaction date
Planned purchase
Price
0.03
Quantity 937,500
Value A$30,000
Glenda McLoughlin Director
Transaction date
Planned purchase
Price
0.03
Quantity 937,500
Value A$30,000
Geoff Cumming Director
Transaction date
Planned purchase
Price
0.03
Quantity 937,500
Value A$30,000
Ewen Crouch Director
Transaction date
Planned purchase
Price
0.03
Quantity 937,500
Value A$30,000
Geoff Cumming Director
Transaction date
Purchase
Price
0.06
Quantity 23
Value A$1
Ewen Crouch Director
Transaction date
Purchase
Price
0.11
Quantity 250,000
Value A$27,675
Geoff Cumming Director
Transaction date
Sale
Price
0.11
Quantity 2,000,000
Value A$220,000
Geoff Cumming Director
Transaction date
Sale
Price
0.22
Quantity 500,000
Value A$108,000
Glenda McLoughlin Director
Transaction date
Purchase
Price
0.23
Quantity 250,000
Value A$56,250
Dr John (Jack) Hamilton Director
Transaction date
Planned purchase
Price
0.26
Quantity 24,069
Value A$6,258
Geoff Cumming Director
Transaction date
Planned purchase
Price
0.26
Quantity 17,369
Value A$4,516
Christopher Parker Director
Transaction date
Planned purchase
Price
0.26
Quantity 17,369
Value A$4,516
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-17 2023-11-14 B Purchase Katherine Woodthorpe Director
46,002
334.08
A$4,751,350 		46,002 334.08 A$4,751,350
2023-11-17 2023-11-14 PP Planned purchase Glenda McLoughlin Director
42,984
206.11
A$1,266,903 		42,984 206.11 A$1,266,903
2023-11-17 2023-11-14 PP Planned purchase Geoff Cumming Director
89,374
290.46
A$1,740,138 		89,374 290.46 A$1,740,138
2023-11-17 2023-11-14 PP Planned purchase Ewen Crouch Director
44
0.03
A$1 		44 0.03 A$1
2023-11-17 2023-11-14 PP Planned purchase David John Radford Director
44
0.03
A$1 		44 0.03 A$1
2023-09-11 2023-09-11 PP Planned purchase David John Radford Director
937,500
0.03
A$30,000 		937,500 0.03 A$30,000
2023-09-11 2023-09-11 PP Planned purchase Glenda McLoughlin Director
937,500
0.03
A$30,000 		937,500 0.03 A$30,000
2023-09-11 2023-09-11 PP Planned purchase Geoff Cumming Director
937,500
0.03
A$30,000 		937,500 0.03 A$30,000
2023-09-11 2023-09-11 PP Planned purchase Ewen Crouch Director
937,500
0.03
A$30,000 		937,500 0.03 A$30,000
2022-12-16 2022-12-16 B Purchase Geoff Cumming Director
23
0.06
A$1 		23 0.06 A$1
2022-05-10 2022-05-09 B Purchase Ewen Crouch Director
250,000
0.11
A$27,675 		250,000 0.11 A$27,675
2022-05-04 2022-05-03 S Sale Geoff Cumming Director
2,000,000
0.11
A$220,000 		2,000,000 0.11 A$220,000
2021-12-24 2021-12-23 S Sale Geoff Cumming Director
500,000
0.22
A$108,000 		500,000 0.22 A$108,000
2021-09-21 2021-09-17 B Purchase Glenda McLoughlin Director
250,000
0.23
A$56,250 		250,000 0.23 A$56,250
2021-05-26 2021-05-25 PP Planned purchase Dr John (Jack) Hamilton Director
24,069
0.26
A$6,258 		24,069 0.26 A$6,258
2021-05-26 2021-05-25 PP Planned purchase Geoff Cumming Director
17,369
0.26
A$4,516 		17,369 0.26 A$4,516
2021-05-26 2021-05-25 PP Planned purchase Christopher Parker Director
17,369
0.26
A$4,516 		17,369 0.26 A$4,516
Explore more

More insider trading research around Anteotech Ltd

More insider trades in Australia
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Asia-Pacific